ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

House Democrats Take More Swings At Tobacco Industry

February 17, 1989

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes

June 11, 1993

2006 demonstration project to pay $23 per office visit.

November 4, 2005

Mammography Guidelines Tightened For BCDDP; September Consensus Meeting Planned

May 13, 1977

President Drops Revision Plan; NCI To Receive $937.1 Million Voted By Congress For FY 1979

January 12, 1979